On an annual basis, states are required to report on their practitioners prescribing habits, cost savings generated from their Drug Utilization Review (DUR) programs and their program’s operations, including adoption of new innovative DUR practices via the Medicaid Drug Utilization Review Annual Report Survey. Please visit the Drug Utilization Review page for more information.
For an overview of Medicaid Prescription Drug Programs visit the Prescription Drugs page.
Fee-for-Service (FFS) National State Drug Utilization Review (DUR) Annual Reports
|2021||FSS||National State Report|
|2020||FSS||National State Report|
|2019||FFS||National State Report|
|2018||FFS||National State Report|
|2017||FFS||National State Report|
|2016||FFS||National State Report|
|2015||FFS||National State Report|
|2014||FFS||National State Report|
|2013||FFS||National State Report|
|2012||FFS||National State Report|
Managed Care Organization (MCO) National State Drug Utilization Review (DUR) Annual Reports
|2021||MCO||National State Report|
|2020||MCO||National State Report|
|2019||MCO||National State Report|
|2018||MCO||National State Report|
42 CFR Subpart K – Drug Use Review (DUR) Program and Electronic Claims Management System for Outpatient Drug Claims Section 456.700-456.725 provides the requirements for the DUR program.
Please direct all communications to the CMSDUR@cms.hhs.gov resource mailbox.
Disclaimer: Please note that the information provided on this web page does not bind or obligate the Centers for Medicare and Medicaid Services (CMS). The statements included on this web page are intended to provide information on CMS Medicaid Drug Utilization Review and do not in any way revise or modify the requirements set forth in Section 1927 of the Act, regulations or program releases.
Page last updated on January 17, 2023